The Economics Burden of Atopic Dermatitis
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-64804-0_8
Reference58 articles.
1. Thorpe KE, Florence CS, Joski P. Which medical conditions account for the rise in health care spending?. Health Aff (Millwood). 2004; Suppl Web Exclusives:W4-437445.
2. Dehkharghani S, Bible J, Chen JG, Feldman SR, Fleischer AB Jr. The economic burden of skin disease in the United States. J Am Acad Dermatol. 2003;48(4):592–9.
3. Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490–500.
4. Martin AB, Hartman M, Washington B, Catlin A, National Health Expenditure Accounts T. National health spending: faster growth in 2015 as coverage expands and utilization increases. Health Aff (Millwood). 2017;36(1):166–76.
5. Hoch JS, Dewa CS. A clinician’s guide to correct cost-effectiveness analysis: think incremental not average. Can J Psychiatry. 2008;53(4):267–74.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial;Dermatology and Therapy;2024-08-30
2. How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence;The Journal of Allergy and Clinical Immunology: In Practice;2024-07
3. Carga clínica, psicosocial y económica de la dermatitis atópica en vida real: resultados de la cohorte española del estudio MEASURE-AD;Actas Dermo-Sifiliográficas;2024-05
4. Efficacy and safety of the regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin (REZPEG) in the treatment of inflammatory skin diseases including atopic dermatitis;2024-01-26
5. Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors;Frontiers in Immunology;2024-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3